Trump DOJ moves to dismiss lawsuit challenging FDA's mifepristone regulations, citing procedural issues and lack of standing.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. Treasury Secretary defends Trump's economic agenda of tariffs, tax cuts, and deregulation as a strategy to attract global investment, despite skepticism from business leaders and economists.
Trump DOJ moves to dismiss lawsuit challenging FDA's mifepristone regulations, citing procedural issues and lack of standing.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. Treasury Secretary defends Trump's economic agenda of tariffs, tax cuts, and deregulation as a strategy to attract global investment, despite skepticism from business leaders and economists.